Uncovering Whether the Evidence

Uncovering Whether the Evidence Supports the Hype Around Antiviral Treatments for COVID-19



In May 2020, we launched our COVID-19 Webinar series.



More than 1,500 people registered for the first webinar, which featured Dr. Gordon Guyatt, Distinguished Professor at McMaster University, and Dr. Tarry Ahuja, Manager of Program Development at CADTH.



Dr. Guyatt discussed “Treatment of Patients With Nonsevere and Severe Coronavirus Disease 2019: An Evidence-Based Guideline,” which had been recently published in the Canadian Medical Association Journal. He also explored the challenges of evidence-based decision-making in a time of crisis and efforts to balance potential benefits and harms.



Dr. Tarry Ahuja summarized recent CADTH reports on remdesivir and hydroxychloroquine, 2 high-profile therapies that were touted as possible treatment options for COVID-19.



The webinar’s success spawned an ongoing webinar series. Another 9 COVID-19 webinars were presented in 2020–2021.